Rotarix
Details for Rotarix vaccine and its components.
Sponsor:
GlaxoSmithKline Australia
Administration route:
Oral
Vaccine group:
Rotavirus vaccines
Registered for use in infants, with an upper age limit for dose 2 of 24 weeks.
Live attenuated human rotavirus vaccine
Each 1.5 mL monodose pre-filled oral applicator or squeezable tube contains:
- ≥106.0 cell culture infectious dose 50% (CCID50) of the RIX4414 human rotavirus strain, type G1P[8]
- di-sodium adipate
- Dulbecco’s modified Eagle medium
- sterile water
For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/rotarix.